These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36511086)

  • 1. Mucosal Addressin Cell Adhesion Molecule 1 Expression Reflects Mucosal Inflammation and Subsequent Relapse in Patients with Ulcerative Colitis.
    Uchiyama K; Takagi T; Mizushima K; Hirai Y; Asaeda K; Sugaya T; Kajiwara-Kubota M; Kashiwagi S; Minagawa Y; Hotta Y; Tanaka M; Inoue K; Katada K; Kamada K; Ishikawa T; Yasuda H; Konishi H; Kishimoto M; Naito Y; Itoh Y
    J Crohns Colitis; 2023 May; 17(5):786-794. PubMed ID: 36511086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis.
    Hozumi H; Hokari R; Kurihara C; Narimatsu K; Sato H; Sato S; Ueda T; Higashiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Kawaguchi A; Nagao S; Miura S
    Int J Colorectal Dis; 2013 Aug; 28(8):1049-55. PubMed ID: 23377880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GlcNAc6ST-1-mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitis.
    Kobayashi M; Hoshino H; Masumoto J; Fukushima M; Suzawa K; Kageyama S; Suzuki M; Ohtani H; Fukuda M; Nakayama J
    Inflamm Bowel Dis; 2009 May; 15(5):697-706. PubMed ID: 19067429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease.
    Arihiro S; Ohtani H; Suzuki M; Murata M; Ejima C; Oki M; Kinouchi Y; Fukushima K; Sasaki I; Nakamura S; Matsumoto T; Torii A; Toda G; Nagura H
    Pathol Int; 2002; 52(5-6):367-74. PubMed ID: 12100519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mucosal IL-12 expression is associated with relapse of ulcerative colitis.
    Uchiyama K; Takagi T; Mizushima K; Kajiwara-Kubota M; Kashiwagi S; Toyokawa Y; Tanaka M; Hotta Y; Kamada K; Ishikawa T; Konishi H; Kishimoto M; Naito Y; Itoh Y
    BMC Gastroenterol; 2021 Mar; 21(1):122. PubMed ID: 33730998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the Inhibitory Effect of Wnt-5a on Colonic Mucosal Inflammation in Patients with Ulcerative Colitis.
    Uchiyama K; Takagi T; Mizushima K; Asaeda K; Kajiwara M; Kashiwagi S; Minagawa Y; Hotta Y; Tanaka M; Inoue K; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Yasuda H; Konishi H; Kishimoto M; Naito Y; Itoh Y
    Dig Dis Sci; 2022 Oct; 67(10):4760-4769. PubMed ID: 35590045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
    Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
    Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the pathogenesis of granulomatous colitis in rats.
    Hokari R; Kato S; Matsuzaki K; Iwai A; Kawaguchi A; Nagao S; Miyahara T; Itoh K; Sekizuka E; Nagata H; Ishii H; Iizuka T; Miyasaka M; Miura S
    Clin Exp Immunol; 2001 Nov; 126(2):259-65. PubMed ID: 11703369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1.
    Kato S; Hokari R; Matsuzaki K; Iwai A; Kawaguchi A; Nagao S; Miyahara T; Itoh K; Ishii H; Miura S
    J Pharmacol Exp Ther; 2000 Oct; 295(1):183-9. PubMed ID: 10991977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal interleukin-8 expression as a predictor of subsequent relapse in ulcerative colitis patients with Mayo endoscopic subscore 0.
    Uchiyama K; Takagi T; Mizushima K; Asaeda K; Kajiwara M; Kashiwagi S; Toyokawa Y; Hotta Y; Tanaka M; Inoue K; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Yasuda H; Konishi H; Kishimoto M; Naito Y; Itoh Y
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1034-1042. PubMed ID: 35233808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations.
    Van den Berghe N; Verstockt B; Gils A; Sabino J; Ferrante M; Vermeire S; Declerck P; Thomas D
    J Crohns Colitis; 2021 Jun; 15(6):988-993. PubMed ID: 33245363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis.
    Stopfer P; Obermeier F; Dunger N; Falk W; Farkas S; Janotta M; Möller A; Männel DN; Hehlgans T
    Clin Exp Immunol; 2004 Apr; 136(1):21-9. PubMed ID: 15030510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals.
    Ozawa N; Yokobori T; Osone K; Bilguun EO; Okami H; Shimoda Y; Shiraishi T; Okada T; Sano A; Sakai M; Sohda M; Miyazaki T; Ide M; Ogawa H; Yao T; Oyama T; Shirabe K; Saeki H
    Int J Cancer; 2024 Jan; 154(2):359-371. PubMed ID: 37676657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Mucosal PNAd
    Roosenboom B; Lochem EGV; Meijer J; Smids C; Nierkens S; Brand EC; Erp LWV; Kemperman LGJM; Groenen MJM; Horje CSHT; Wahab PJ
    Cells; 2020 Apr; 9(4):. PubMed ID: 32268498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
    Kevans D; Kirsch R; Dargavel C; Kabakchiev B; Riddell R; Silverberg MS
    Inflamm Bowel Dis; 2020 Oct; 26(11):1722-1729. PubMed ID: 31883337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis.
    Ye X; Wu J; Li J; Wang H
    Biomed Res Int; 2021; 2021():6483860. PubMed ID: 34055987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease.
    Souza HS; Elia CC; Spencer J; MacDonald TT
    Gut; 1999 Dec; 45(6):856-63. PubMed ID: 10562584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Histo-endoscopic Remission but not Endoscopic Healing Alone in Ulcerative Colitis is Associated with a Mucosal Transcriptional Profile Resembling Healthy Mucosa.
    Hernández-Rocha C; Nayeri S; Turpin W; Steel M; Borowski K; Stempak JM; Conner J; Silverberg MS
    J Crohns Colitis; 2022 Aug; 16(7):1020-1029. PubMed ID: 34999763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MADCAM therapy for ulcerative colitis.
    Picardo S; Panaccione R
    Expert Opin Biol Ther; 2020 Apr; 20(4):437-442. PubMed ID: 31709847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.